| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.804 | 0.011 | 0.804 | Caspase 9 stimulant | 0.772 0.015 CID_124202102 | ||
| 0.757 | 0.003 | 0.757 | Superoxide dismutase inhibitor | 0.24 0.081 CID_124202102 | ||
| 0.733 | 0.025 | 0.753 | Apoptosis agonist | 0.753 0.023 CID_124202102 | CID_124202102 | |
| 0.713 | 0.019 | 0.914 | Transcription factor NF kappa B inhibitor | 0.914 0.005 CID_124202102 | CID_124202102 | |
| 0.677 | 0.005 | 0.721 | Free radical scavenger | 0.721 0.005 CID_124202102 | CID_124202102 | |
| 0.674 | 0.007 | 0.773 | Antioxidant | 0.773 0.005 CID_124202102 | CID_124202102 | |
| 0.657 | 0.012 | 0.657 | Aldehyde oxidase inhibitor | |||
| 0.647 | 0.006 | 0.647 | Amyloid beta aggregation inhibitor | 0.394 0.026 CID_124202102 | ||
| 0.632 | 0.004 | 0.778 | Melanin inhibitor | 0.778 0.002 CID_124202102 | CID_124202102 | |
| 0.618 | 0.005 | 0.618 | Tubulin antagonist | 0.178 0.045 CID_124202102 | ||
| 0.616 | 0.009 | 0.616 | Lipoxygenase inhibitor | |||
| 0.552 | 0.004 | 0.552 | Interleukin 1b antagonist | 0.355 0.006 CID_124202102 | ||
| 0.593 | 0.055 | 0.817 | Antiinflammatory | 0.817 0.013 CID_124202102 | CID_124202102 | |
| 0.556 | 0.019 | 0.556 | 5 Hydroxytryptamine release stimulant | 0.449 0.036 CID_124202102 | ||
| 0.553 | 0.031 | 0.553 | 15-Lipoxygenase inhibitor | |||
| 0.531 | 0.01 | 0.531 | Antimitotic | 0.279 0.05 CID_124202102 | ||
| 0.524 | 0.005 | 0.524 | Interleukin 1 antagonist | 0.272 0.015 CID_124202102 | ||
| 0.509 | 0.02 | 0.509 | 12-Lipoxygenase inhibitor | |||
| 0.502 | 0.014 | 0.695 | Tumour necrosis factor alpha release inhibitor | 0.695 0.005 CID_124202102 | CID_124202102 | |
| 0.501 | 0.016 | 0.615 | Nitric oxide antagonist | 0.615 0.009 CID_124202102 | CID_124202102 | |
| 0.503 | 0.02 | 0.608 | Apoptosis antagonist | 0.608 0.009 CID_124202102 | CID_124202102 | |
| 0.49 | 0.008 | 0.761 | Monophenol monooxygenase inhibitor | 0.761 0.003 CID_124202102 | CID_124202102 | |
| 0.507 | 0.026 | 0.518 | Vasodilator, peripheral | 0.518 0.025 CID_124202102 | CID_124202102 | |
| 0.488 | 0.017 | 0.692 | Vasodilator, coronary | 0.692 0.005 CID_124202102 | CID_124202102 | |
| 0.466 | 0.01 | 0.496 | Anesthetic general | 0.496 0.008 CID_124202102 | CID_124202102 | |
| 0.489 | 0.034 | 0.67 | Cholesterol antagonist | 0.67 0.01 CID_124202102 | CID_124202102 | |
| 0.455 | 0.005 | 0.455 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.467 | 0.025 | 0.467 | Caspase 3 stimulant | 0.419 0.039 CID_124202102 | ||
| 0.478 | 0.037 | 0.622 | Histamine release inhibitor | 0.622 0.008 CID_124202102 | CID_124202102 | |
| 0.453 | 0.024 | 0.453 | Interleukin antagonist | 0.241 0.065 CID_124202102 | ||
| 0.441 | 0.015 | 0.441 | Peroxidase inhibitor | |||
| 0.444 | 0.021 | 0.444 | Hypoxia-inducible factor 1 alpha inhibitor | 0.419 0.026 CID_124202102 | ||
| 0.428 | 0.007 | 0.608 | DNA methyltransferase I inhibitor | 0.608 0.004 CID_124202102 | CID_124202102 | |
| 0.426 | 0.008 | 0.75 | Amylase inhibitor | 0.75 0.003 CID_124202102 | CID_124202102 | |
| 0.435 | 0.018 | 0.503 | Vasodilator | 0.503 0.012 CID_124202102 | CID_124202102 | |
| 0.436 | 0.023 | 0.498 | Antiamyloidogenic | 0.498 0.016 CID_124202102 | CID_124202102 | |
| 0.419 | 0.014 | 0.419 | P-glycoprotein inhibitor | 0.316 0.026 CID_124202102 | ||
| 0.416 | 0.012 | 0.416 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.484 | 0.085 | 0.733 | Alpha-glucosidase inhibitor | 0.733 0.028 CID_124202102 | CID_124202102 | |
| 0.399 | 0.004 | 0.399 | Succinate dehydrogenase inhibitor | 0.178 0.07 CID_124202102 | ||
| 0.396 | 0.004 | 0.396 | Beta tubulin antagonist | |||
| 0.408 | 0.017 | 0.408 | Transcription factor STAT3 inhibitor | 0.203 0.129 CID_124202102 | ||
| 0.409 | 0.021 | 0.409 | Calcium channel activator | |||
| 0.404 | 0.021 | 0.404 | Sigma receptor agonist | |||
| 0.392 | 0.011 | 0.594 | DNA methylase inhibitor | 0.594 0.004 CID_124202102 | CID_124202102 | |
| 0.439 | 0.061 | 0.705 | Antibacterial | 0.705 0.008 CID_124202102 | CID_124202102 | |
| 0.404 | 0.028 | 0.405 | DNA damaging | 0.405 0.028 CID_124202102 | CID_124202102 | |
| 0.374 | 0.003 | 0.374 | Vanilloid 1 agonist | 0.263 0.005 CID_124202102 | ||
| 0.373 | 0.005 | 0.373 | Cystathionine beta-synthase inhibitor | 0.284 0.011 CID_124202102 | ||
| 0.373 | 0.006 | 0.373 | 5-Lipoxygenase inhibitor | |||
| 0.388 | 0.022 | 0.388 | Transcription factor STAT inhibitor | |||
| 0.374 | 0.01 | 0.518 | Protein kinase stimulant | 0.518 0.004 CID_124202102 | CID_124202102 | |
| 0.353 | 0.006 | 0.777 | Expectorant | 0.777 0.002 CID_124202102 | CID_124202102 | |
| 0.383 | 0.042 | 0.383 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.351 | 0.011 | 0.409 | NOS3 expression enhancer | 0.409 0.008 CID_124202102 | CID_124202102 | |
| 0.353 | 0.019 | 0.644 | Non-steroidal antiinflammatory agent | 0.644 0.004 CID_124202102 | CID_124202102 | |
| 0.344 | 0.011 | 0.344 | Tumour necrosis factor antagonist | 0.179 0.068 CID_124202102 | ||
| 0.356 | 0.024 | 0.562 | Cyclic AMP phosphodiesterase inhibitor | 0.562 0.005 CID_124202102 | CID_124202102 | |
| 0.344 | 0.014 | 0.386 | Lipid peroxidase inhibitor | 0.386 0.01 CID_124202102 | CID_124202102 | |
| 0.356 | 0.027 | 0.478 | Interleukin agonist | 0.478 0.01 CID_124202102 | CID_124202102 | |
| 0.356 | 0.032 | 0.356 | Pyruvate kinase inhibitor | |||
| 0.344 | 0.02 | 0.576 | Hepatoprotectant | 0.576 0.005 CID_124202102 | CID_124202102 | |
| 0.386 | 0.069 | 0.541 | Immunosuppressant | 0.541 0.023 CID_124202102 | CID_124202102 | |
| 0.325 | 0.01 | 0.325 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.318 | 0.007 | 0.318 | Breast cancer-resistant protein inhibitor | |||
| 0.326 | 0.016 | 0.506 | Interferon gamma antagonist | 0.506 0.006 CID_124202102 | CID_124202102 | |
| 0.348 | 0.041 | 0.348 | Sodium/bile acid cotransporter inhibitor | 0.266 0.111 CID_124202102 | ||
| 0.304 | 0.004 | 0.304 | Keratolytic | 0.076 0.055 CID_124202102 | ||
| 0.303 | 0.006 | 0.468 | ATPase inhibitor | 0.468 0.003 CID_124202102 | CID_124202102 | |
| 0.298 | 0.006 | 0.298 | Carbonic anhydrase VI inhibitor | 0.126 0.027 CID_124202102 | ||
| 0.34 | 0.056 | 0.469 | Spasmolytic | 0.469 0.028 CID_124202102 | CID_124202102 | |
| 0.325 | 0.044 | 0.667 | Hypoglycemic | 0.667 0.005 CID_124202102 | CID_124202102 | |
| 0.289 | 0.015 | 0.289 | Cyclooxygenase 1 inhibitor | 0.171 0.047 CID_124202102 | ||
| 0.299 | 0.034 | 0.466 | Platelet adhesion inhibitor | 0.466 0.007 CID_124202102 | CID_124202102 | |
| 0.269 | 0.007 | 0.269 | Carbonic anhydrase III inhibitor | 0.141 0.032 CID_124202102 | ||
| 0.272 | 0.015 | 0.272 | Cholesterol synthesis inhibitor | 0.168 0.036 CID_124202102 | ||
| 0.264 | 0.006 | 0.264 | HIV-1 integrase (3'-Processing) inhibitor | 0.097 0.027 CID_124202102 | ||
| 0.265 | 0.008 | 0.312 | Carbonic anhydrase XIII inhibitor | 0.312 0.005 CID_124202102 | CID_124202102 | |
| 0.259 | 0.008 | 0.259 | Toll-Like receptor 2 antagonist | 0.119 0.078 CID_124202102 | ||
| 0.271 | 0.021 | 0.271 | Nitric-oxide synthase stimulant | 0.264 0.024 CID_124202102 | ||
| 0.274 | 0.027 | 0.284 | Neurotrophic factor enhancer | 0.284 0.023 CID_124202102 | CID_124202102 | |
| 0.374 | 0.127 | 0.374 | DNA directed DNA polymerase inhibitor | |||
| 0.356 | 0.11 | 0.469 | 5 Hydroxytryptamine release inhibitor | 0.469 0.044 CID_124202102 | CID_124202102 | |
| 0.368 | 0.123 | 0.368 | Transcription factor inhibitor | |||
| 0.248 | 0.005 | 0.248 | Vanilloid agonist | 0.098 0.035 CID_124202102 | ||
| 0.287 | 0.046 | 0.292 | Psychostimulant | 0.292 0.045 CID_124202102 | CID_124202102 | |
| 0.333 | 0.095 | 0.333 | GABA C receptor rho-3 antagonist | |||
| 0.24 | 0.005 | 0.24 | Alpha tubulin antagonist | |||
| 0.247 | 0.013 | 0.383 | Xanthine oxidase inhibitor | 0.383 0.005 CID_124202102 | CID_124202102 | |
| 0.325 | 0.091 | 0.325 | Prostaglandin dehydrogenase inhibitor | |||
| 0.246 | 0.013 | 0.246 | Carbonic anhydrase XV inhibitor | |||
| 0.268 | 0.035 | 0.268 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.194 0.077 CID_124202102 | ||
| 0.294 | 0.062 | 0.294 | Insulysin inhibitor | |||
| 0.26 | 0.029 | 0.26 | Insulin sensitizer | 0.225 0.051 CID_124202102 | ||
| 0.302 | 0.072 | 0.455 | Interleukin 2 agonist | 0.455 0.015 CID_124202102 | CID_124202102 | |
| 0.277 | 0.048 | 0.277 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.257 | 0.03 | 0.257 | Amyloid beta precursor protein antagonist | |||
| 0.309 | 0.083 | 0.731 | Antithrombotic | 0.731 0.007 CID_124202102 | CID_124202102 | |
| 0.239 | 0.015 | 0.239 | Interleukin 4 antagonist | 0.175 0.032 CID_124202102 | ||
| 0.246 | 0.026 | 0.246 | Phospholipase C inhibitor | 0.177 0.064 CID_124202102 | ||
| 0.225 | 0.007 | 0.225 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.229 | 0.012 | 0.229 | Arachidonic acid antagonist | 0.172 0.063 CID_124202102 | ||
| 0.224 | 0.007 | 0.224 | TRPA1 agonist | 0.158 0.026 CID_124202102 | ||
| 0.236 | 0.027 | 0.236 | Cytokine production inhibitor | |||
| 0.217 | 0.008 | 0.217 | Adenylate cyclase stimulant | 0.148 0.066 CID_124202102 | ||
| 0.223 | 0.015 | 0.246 | Microtubule formation inhibitor | 0.246 0.01 CID_124202102 | CID_124202102 | |
| 0.268 | 0.062 | 0.756 | Angiogenesis stimulant | 0.756 0.004 CID_124202102 | CID_124202102 | |
| 0.213 | 0.009 | 0.213 | HIV-1 integrase (Strand Transfer) inhibitor | 0.08 0.031 CID_124202102 | ||
| 0.265 | 0.061 | 0.381 | Hypolipemic | 0.381 0.029 CID_124202102 | CID_124202102 | |
| 0.203 | 0.006 | 0.203 | Heat shock protein 70 antagonist | 0.197 0.007 CID_124202102 | ||
| 0.294 | 0.096 | 0.324 | Angiogenesis inhibitor | 0.324 0.081 CID_124202102 | CID_124202102 | |
| 0.218 | 0.021 | 0.218 | Chelator | |||
| 0.229 | 0.033 | 0.229 | MAO inhibitor | |||
| 0.34 | 0.144 | 0.34 | DNA polymerase beta inhibitor | |||
| 0.202 | 0.012 | 0.576 | Beta glucuronidase inhibitor | 0.576 0.003 CID_124202102 | CID_124202102 | |
| 0.242 | 0.057 | 0.406 | Peptidyltransferase inhibitor | 0.406 0.006 CID_124202102 | CID_124202102 | |
| 0.193 | 0.015 | 0.215 | Mucolytic | 0.215 0.01 CID_124202102 | CID_124202102 | |
| 0.182 | 0.005 | 0.185 | Neuraminidase (influenza) inhibitor | 0.185 0.005 CID_124202102 | CID_124202102 | |
| 0.188 | 0.014 | 0.188 | Estrogen antagonist | 0.108 0.079 CID_124202102 | ||
| 0.203 | 0.03 | 0.203 | Catenin beta inhibitor | |||
| 0.209 | 0.038 | 0.209 | Cyclooxygenase inhibitor | 0.137 0.081 CID_124202102 | ||
| 0.232 | 0.062 | 0.232 | ErbB-1 antagonist | |||
| 0.2 | 0.032 | 0.2 | Anesthetic local | |||
| 0.2 | 0.033 | 0.3 | Topoisomerase II inhibitor | 0.3 0.018 CID_124202102 | CID_124202102 | |
| 0.196 | 0.033 | 0.196 | Mannose-6-phosphate isomerase inhibitor | 0.175 0.045 CID_124202102 | ||
| 0.228 | 0.066 | 0.228 | RNA-directed DNA polymerase inhibitor | 0.178 0.136 CID_124202102 | ||
| 0.172 | 0.012 | 0.172 | Ca2+-transporting ATPase inhibitor | 0.166 0.016 CID_124202102 | ||
| 0.191 | 0.031 | 0.191 | MAO A inhibitor | |||
| 0.172 | 0.013 | 0.172 | Electron transport complex I inhibitor | 0.112 0.058 CID_124202102 | ||
| 0.163 | 0.005 | 0.163 | Neuraminidase inhibitor | 0.158 0.005 CID_124202102 | ||
| 0.162 | 0.005 | 0.162 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.125 0.011 CID_124202102 | ||
| 0.161 | 0.005 | 0.161 | ATPase (Vacuolar H+) inhibitor | 0.16 0.005 CID_124202102 | ||
| 0.173 | 0.019 | 0.173 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.18 | 0.027 | 0.424 | Cyclooxygenase 3 inhibitor | 0.424 0.004 CID_124202102 | CID_124202102 | |
| 0.19 | 0.037 | 0.19 | Alkaline phosphatase inhibitor | 0.17 0.048 CID_124202102 | ||
| 0.2 | 0.048 | 0.2 | Cytidine deaminase inhibitor | |||
| 0.229 | 0.078 | 0.229 | Neuropeptide Y2 antagonist | |||
| 0.208 | 0.058 | 0.208 | Histone acetyltransferase inhibitor | |||
| 0.177 | 0.029 | 0.177 | MAO B inhibitor | |||
| 0.163 | 0.015 | 0.192 | Toll-Like receptor 4 antagonist | 0.192 0.007 CID_124202102 | CID_124202102 | |
| 0.166 | 0.02 | 0.227 | Topoisomerase II alpha inhibitor | 0.227 0.012 CID_124202102 | CID_124202102 | |
| 0.179 | 0.033 | 0.35 | Alkylator | 0.35 0.01 CID_124202102 | CID_124202102 | |
| 0.187 | 0.043 | 0.187 | Neurotensin receptor agonist | |||
| 0.183 | 0.039 | 0.183 | Acetylcholinesterase inhibitor | |||
| 0.179 | 0.035 | 0.179 | DNA polymerase I inhibitor | 0.17 0.039 CID_124202102 | ||
| 0.16 | 0.018 | 0.16 | Histidine decarboxylase inhibitor | |||
| 0.148 | 0.005 | 0.148 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.156 | 0.014 | 0.156 | Macrophage migration inhibitory factor inhibitor | |||
| 0.16 | 0.022 | 0.16 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.156 | 0.018 | 0.156 | DOPA decarboxylase inhibitor | |||
| 0.152 | 0.016 | 0.152 | Inducible nitric-oxide synthase inhibitor | |||
| 0.148 | 0.012 | 0.148 | Estrogen receptor alpha antagonist | |||
| 0.15 | 0.014 | 0.15 | Carbonic anhydrase V inhibitor | |||
| 0.15 | 0.015 | 0.15 | Estrogen receptor beta antagonist | |||
| 0.177 | 0.042 | 0.337 | Alpha-N-acetylglucosaminidase inhibitor | 0.337 0.013 CID_124202102 | CID_124202102 | |
| 0.146 | 0.012 | 0.146 | Ornithine decarboxylase inhibitor | 0.111 0.033 CID_124202102 | ||
| 0.223 | 0.091 | 0.223 | Aryl hydrocarbon receptor agonist | |||
| 0.185 | 0.053 | 0.185 | Protein-tyrosine phosphatase inhibitor | 0.158 0.071 CID_124202102 | ||
| 0.152 | 0.021 | 0.152 | Prolactin inhibitor | |||
| 0.175 | 0.044 | 0.333 | Cell wall synthesis inhibitor | 0.333 0.008 CID_124202102 | CID_124202102 | |
| 0.142 | 0.011 | 0.142 | Thioredoxin reductase inhibitor | 0.088 0.043 CID_124202102 | ||
| 0.14 | 0.01 | 0.14 | HIV-1 integrase inhibitor | |||
| 0.257 | 0.129 | 0.257 | Thioredoxin glutathione reductase inhibitor | |||
| 0.145 | 0.018 | 0.159 | Thioredoxin inhibitor | 0.159 0.014 CID_124202102 | CID_124202102 | |
| 0.174 | 0.048 | 0.174 | GABA C receptor rho-2 antagonist | |||
| 0.148 | 0.023 | 0.148 | Calcium antagonist | |||
| 0.135 | 0.012 | 0.135 | Estrogen agonist | 0.09 0.02 CID_124202102 | ||
| 0.135 | 0.014 | 0.135 | Carbonic anhydrase VA inhibitor | |||
| 0.125 | 0.004 | 0.141 | Glucose-6-phosphate translocase inhibitor | 0.141 0.004 CID_124202102 | CID_124202102 | |
| 0.136 | 0.016 | 0.136 | Glutathione S-transferase inhibitor | |||
| 0.147 | 0.027 | 0.147 | Catalase inhibitor | |||
| 0.165 | 0.044 | 0.165 | Cyclooxygenase 2 inhibitor | 0.112 0.089 CID_124202102 | ||
| 0.145 | 0.027 | 0.147 | Sphingomyelinase inhibitor | 0.147 0.026 CID_124202102 | CID_124202102 | |
| 0.133 | 0.015 | 0.133 | Myeloperoxidase inhibitor | |||
| 0.158 | 0.043 | 0.158 | Protein-tyrosine phosphatase 1B inhibitor | 0.156 0.043 CID_124202102 | ||
| 0.146 | 0.032 | 0.284 | Antineoplastic antibiotic | 0.284 0.011 CID_124202102 | CID_124202102 | |
| 0.127 | 0.016 | 0.127 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.125 | 0.014 | 0.125 | GABA aminotransferase inhibitor | 0.105 0.023 CID_124202102 | ||
| 0.159 | 0.049 | 0.159 | NADPH oxidase inhibitor | 0.129 0.072 CID_124202102 | ||
| 0.128 | 0.019 | 0.193 | Phosphodiesterase 6D inhibitor | 0.193 0.005 CID_124202102 | CID_124202102 | |
| 0.213 | 0.104 | 0.383 | DNA synthesis inhibitor | 0.383 0.024 CID_124202102 | CID_124202102 | |
| 0.138 | 0.03 | 0.138 | Urease inhibitor | |||
| 0.168 | 0.06 | 0.168 | Phospholipase A2 inhibitor | 0.136 0.091 CID_124202102 | ||
| 0.118 | 0.011 | 0.118 | Estrogen-related receptor beta agonist | |||
| 0.111 | 0.004 | 0.111 | Transcription factor RelA inhibitor | |||
| 0.136 | 0.031 | 0.136 | Creatine kinase inhibitor | |||
| 0.178 | 0.075 | 0.178 | Dual specificity phosphatase 3 inhibitor | |||
| 0.15 | 0.047 | 0.15 | Proteasome inhibitor | |||
| 0.106 | 0.007 | 0.106 | Exportin-1 inhibitor | |||
| 0.169 | 0.07 | 0.169 | Heat shock protein 90 alpha antagonist | |||
| 0.119 | 0.021 | 0.119 | Glutamate decarboxylase inhibitor | |||
| 0.168 | 0.074 | 0.168 | Mcl-1 antagonist | |||
| 0.132 | 0.038 | 0.322 | Mediator release inhibitor | 0.322 0.006 CID_124202102 | CID_124202102 | |
| 0.158 | 0.066 | 0.158 | Heat shock protein 90 antagonist | |||
| 0.101 | 0.011 | 0.132 | Carbonic anhydrase XIV inhibitor | 0.132 0.006 CID_124202102 | CID_124202102 | |
| 0.133 | 0.043 | 0.133 | Caspase 3 inhibitor | |||
| 0.094 | 0.005 | 0.094 | Catechol O-methyltransferase inhibitor | |||
| 0.166 | 0.078 | 0.166 | Dual specificity phosphatase inhibitor | |||
| 0.107 | 0.019 | 0.107 | Leukotriene antagonist | 0.091 0.026 CID_124202102 | ||
| 0.141 | 0.053 | 0.152 | Aldehyde dehydrogenase inhibitor | 0.152 0.046 CID_124202102 | CID_124202102 | |
| 0.101 | 0.013 | 0.101 | Transcription factor AP-1 inhibitor | 0.084 0.019 CID_124202102 | ||
| 0.126 | 0.039 | 0.129 | Acetylcholine release stimulant | 0.129 0.036 CID_124202102 | CID_124202102 | |
| 0.155 | 0.068 | 0.155 | CF transmembrane conductance regulator agonist | |||
| 0.134 | 0.048 | 0.252 | Topoisomerase I inhibitor | 0.252 0.016 CID_124202102 | CID_124202102 | |
| 0.092 | 0.006 | 0.092 | Squalene epoxidase inhibitor | 0.05 0.035 CID_124202102 | ||
| 0.1 | 0.016 | 0.1 | Carbonic anhydrase VB inhibitor | |||
| 0.088 | 0.005 | 0.088 | Factor III inhibitor | 0.083 0.006 CID_124202102 | ||
| 0.088 | 0.007 | 0.088 | Vanilloid 2 antagonist | |||
| 0.097 | 0.017 | 0.097 | Xanthine dehydrogenase inhibitor | |||
| 0.122 | 0.043 | 0.122 | Bronchodilator | 0.096 0.069 CID_124202102 | ||
| 0.136 | 0.057 | 0.136 | Cathepsin H inhibitor | |||
| 0.123 | 0.045 | 0.135 | Multidrug resistance-associated protein 1 inhibitor | 0.135 0.034 CID_124202102 | CID_124202102 | |
| 0.103 | 0.026 | 0.103 | D-Ala-D-Ala ligase inhibitor | |||
| 0.087 | 0.011 | 0.087 | Heme oxygenase stimulant | 0.06 0.046 CID_124202102 | ||
| 0.094 | 0.021 | 0.094 | GABA B receptor agonist | |||
| 0.086 | 0.014 | 0.086 | Beta 1 adrenoreceptor antagonist | |||
| 0.083 | 0.011 | 0.083 | Potassium channel Kv1.3 blocker | |||
| 0.091 | 0.02 | 0.091 | Beta adrenoreceptor antagonist | |||
| 0.093 | 0.023 | 0.093 | Aromatase inhibitor | |||
| 0.114 | 0.045 | 0.114 | Anabolic | |||
| 0.119 | 0.05 | 0.318 | AMP-activated protein kinase stimulant | 0.318 0.005 CID_124202102 | CID_124202102 | |
| 0.081 | 0.013 | 0.081 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.137 | 0.07 | 0.137 | Farnesoid X receptor antagonist | |||
| 0.076 | 0.009 | 0.076 | Pregnane X receptor antagonist | |||
| 0.088 | 0.022 | 0.088 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.075 | 0.01 | 0.075 | Adenylate cyclase 1 inhibitor | |||
| 0.133 | 0.068 | 0.133 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.08 | 0.015 | 0.116 | Leukotriene B4 antagonist | 0.116 0.008 CID_124202102 | CID_124202102 | |
| 0.072 | 0.008 | 0.072 | Dopamine D5 agonist | |||
| 0.069 | 0.005 | 0.069 | Kainate receptor agonist | 0.042 0.027 CID_124202102 | ||
| 0.104 | 0.04 | 0.104 | Bile acid receptor antagonist | |||
| 0.109 | 0.045 | 0.141 | Uric acid excretion stimulant | 0.141 0.027 CID_124202102 | CID_124202102 | |
| 0.136 | 0.073 | 0.136 | Neurotrophic factor | |||
| 0.119 | 0.058 | 0.176 | Photosensitizer | 0.176 0.019 CID_124202102 | CID_124202102 | |
| 0.109 | 0.047 | 0.109 | Nitric-oxide synthase inhibitor | |||
| 0.093 | 0.032 | 0.125 | Histone deacetylase stimulant | 0.125 0.016 CID_124202102 | CID_124202102 | |
| 0.093 | 0.032 | 0.125 | Histone deacetylase SIRT1 stimulant | 0.125 0.016 CID_124202102 | CID_124202102 | |
| 0.074 | 0.013 | 0.074 | Estrogen receptor alpha agonist | |||
| 0.129 | 0.068 | 0.129 | Antibacterial (Helicobacter pylori) | |||
| 0.124 | 0.063 | 0.129 | Beta amyloid protein antagonist | 0.129 0.058 CID_124202102 | CID_124202102 | |
| 0.08 | 0.019 | 0.08 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.102 | 0.042 | 0.179 | NADH dehydrogenase inhibitor | 0.179 0.012 CID_124202102 | CID_124202102 | |
| 0.149 | 0.09 | 0.2 | Interleukin 6 antagonist | 0.2 0.04 CID_124202102 | CID_124202102 | |
| 0.072 | 0.015 | 0.072 | Ryanodine receptor antagonist | |||
| 0.119 | 0.062 | 0.119 | Transcription factor STAT6 inhibitor | |||
| 0.08 | 0.024 | 0.08 | Alcohol oxidase inhibitor | |||
| 0.108 | 0.053 | 0.245 | UDP-glucose 4-epimerase inhibitor | 0.245 0.014 CID_124202102 | CID_124202102 | |
| 0.176 | 0.121 | 0.381 | Platelet antagonist | 0.381 0.031 CID_124202102 | CID_124202102 | |
| 0.086 | 0.031 | 0.086 | Glycine receptor agonist | 0.076 0.044 CID_124202102 | ||
| 0.081 | 0.026 | 0.081 | Aryl hydrocarbon receptor antagonist | |||
| 0.122 | 0.068 | 0.122 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.184 | 0.13 | 0.469 | Immunostimulant | 0.469 0.033 CID_124202102 | CID_124202102 | |
| 0.099 | 0.046 | 0.099 | Polo-like kinase-1 inhibitor | |||
| 0.078 | 0.026 | 0.078 | Purinergic P2X1 antagonist | |||
| 0.088 | 0.036 | 0.088 | CDC25A inhibitor | |||
| 0.099 | 0.048 | 0.099 | Androgen antagonist | |||
| 0.253 | 0.202 | 0.253 | Calcium channel L-type activator | |||
| 0.174 | 0.123 | 0.174 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.073 | 0.023 | 0.073 | Calcium channel P-type blocker | |||
| 0.064 | 0.017 | 0.064 | Estrogen receptor beta agonist | |||
| 0.148 | 0.104 | 0.148 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.123 | 0.079 | 0.123 | Toll-Like receptor antagonist | |||
| 0.053 | 0.01 | 0.053 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.058 | 0.017 | 0.058 | Dopamine beta hydroxylase inhibitor | |||
| 0.086 | 0.045 | 0.114 | Na+ K+ transporting ATPase inhibitor | 0.114 0.02 CID_124202102 | CID_124202102 | |
| 0.055 | 0.014 | 0.055 | Dihydrofolate reductase inhibitor | |||
| 0.113 | 0.073 | 0.113 | Adenylate cyclase inhibitor | |||
| 0.063 | 0.023 | 0.063 | Leukotriene C antagonist | |||
| 0.062 | 0.022 | 0.062 | Beta 2 adrenoreceptor antagonist | |||
| 0.092 | 0.052 | 0.098 | Interleukin 5 antagonist | 0.098 0.043 CID_124202102 | CID_124202102 | |
| 0.067 | 0.028 | 0.067 | Fatty acid synthase inhibitor | |||
| 0.063 | 0.024 | 0.063 | Dihydroorotate oxidase inhibitor | |||
| 0.08 | 0.041 | 0.091 | Phosphodiesterase VI inhibitor | 0.091 0.027 CID_124202102 | CID_124202102 | |
| 0.071 | 0.032 | 0.071 | Beta 3 adrenoreceptor antagonist | |||
| 0.102 | 0.064 | 0.102 | GABA C receptor agonist | |||
| 0.048 | 0.01 | 0.048 | Vanilloid 3 antagonist | |||
| 0.06 | 0.023 | 0.225 | Heparanase inhibitor | 0.225 0.002 CID_124202102 | CID_124202102 | |
| 0.07 | 0.033 | 0.076 | Prostaglandin EP2 antagonist | 0.076 0.029 CID_124202102 | CID_124202102 | |
| 0.05 | 0.015 | 0.05 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.134 | 0.099 | 0.24 | Hexokinase inhibitor | 0.24 0.019 CID_124202102 | CID_124202102 | |
| 0.066 | 0.031 | 0.066 | Maillard reaction inhibitor | |||
| 0.057 | 0.021 | 0.057 | Carbonic anhydrase VII inhibitor | |||
| 0.131 | 0.097 | 0.131 | Pregnane X receptor agonist | |||
| 0.053 | 0.019 | 0.068 | Neuraminidase (Influenza A) inhibitor | 0.068 0.008 CID_124202102 | CID_124202102 | |
| 0.092 | 0.06 | 0.092 | Protein kinase C delta inhibitor | |||
| 0.075 | 0.043 | 0.075 | Amidase inhibitor | |||
| 0.099 | 0.067 | 0.099 | Alpha 2c adrenoreceptor antagonist | |||
| 0.07 | 0.038 | 0.07 | CDC25B inhibitor | |||
| 0.088 | 0.057 | 0.088 | Alpha 2 adrenoreceptor antagonist | |||
| 0.078 | 0.049 | 0.078 | Porphobilinogen synthase inhibitor | |||
| 0.071 | 0.043 | 0.071 | Leukotriene synthesis inhibitor | |||
| 0.094 | 0.067 | 0.094 | Butyrylcholinesterase inhibitor | |||
| 0.129 | 0.102 | 0.129 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.127 | 0.1 | 0.127 | Cholinergic | |||
| 0.04 | 0.015 | 0.04 | Tubulin agonist | 0.032 0.03 CID_124202102 | ||
| 0.044 | 0.018 | 0.044 | Retinoid X receptor antagonist | |||
| 0.095 | 0.07 | 0.095 | GABA C receptor rho-1 antagonist | |||
| 0.041 | 0.017 | 0.041 | Estrogen-related receptor alpha antagonist | |||
| 0.039 | 0.016 | 0.039 | HMG CoA reductase inhibitor | 0.036 0.02 CID_124202102 | ||
| 0.095 | 0.072 | 0.095 | Gastric antisecretory | |||
| 0.057 | 0.034 | 0.097 | Aldose reductase inhibitor | 0.097 0.019 CID_124202102 | CID_124202102 | |
| 0.091 | 0.07 | 0.091 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.059 | 0.038 | 0.073 | Lipocortins synthesis agonist | 0.073 0.019 CID_124202102 | CID_124202102 | |
| 0.1 | 0.079 | 0.1 | GABA C receptor antagonist | |||
| 0.088 | 0.068 | 0.133 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.133 0.033 CID_124202102 | CID_124202102 | |
| 0.096 | 0.075 | 0.096 | Adenylate kinase inhibitor | |||
| 0.067 | 0.047 | 0.067 | Purinergic P2X2 antagonist | |||
| 0.04 | 0.022 | 0.04 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.03 | 0.013 | 0.03 | Nicotinic acid receptor 2 antagonist | |||
| 0.07 | 0.055 | 0.07 | Metalloproteinase-9 inhibitor | |||
| 0.025 | 0.01 | 0.025 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.027 | 0.012 | 0.027 | CYP24 inhibitor | |||
| 0.04 | 0.025 | 0.04 | Leukotriene C4 antagonist | |||
| 0.036 | 0.021 | 0.036 | Retinoid X alpha receptor antagonist | |||
| 0.052 | 0.04 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.036 | 0.024 | 0.036 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.075 | 0.063 | 0.075 | MAP kinase kinase 7 inhibitor | |||
| 0.054 | 0.043 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.018 CID_124202102 | CID_124202102 | |
| 0.06 | 0.049 | 0.06 | Dopamine D1 antagonist | |||
| 0.08 | 0.069 | 0.169 | Transcription factor NF kappa B stimulant | 0.169 0.013 CID_124202102 | CID_124202102 | |
| 0.024 | 0.014 | 0.024 | Dopamine D1 agonist | 0.021 0.019 CID_124202102 | ||
| 0.022 | 0.011 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.046 | 0.036 | 0.069 | Glucose-6-phosphate isomerase inhibitor | 0.069 0.013 CID_124202102 | CID_124202102 | |
| 0.053 | 0.042 | 0.053 | Sphingosine kinase 2 inhibitor | |||
| 0.109 | 0.099 | 0.109 | Toll-Like receptor 9 antagonist | |||
| 0.047 | 0.037 | 0.047 | Topoisomerase II beta inhibitor | |||
| 0.055 | 0.045 | 0.055 | Botulinum neurotoxin type A inhibitor | |||
| 0.022 | 0.012 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.029 | 0.019 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.026 | 0.017 | 0.104 | Sodium/glucose cotransporter inhibitor | 0.104 0.003 CID_124202102 | CID_124202102 | |
| 0.051 | 0.041 | 0.051 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.085 | 0.076 | 0.092 | Glutamate release inhibitor | 0.092 0.056 CID_124202102 | CID_124202102 | |
| 0.034 | 0.025 | 0.034 | Retinoid X alpha receptor agonist | |||
| 0.063 | 0.054 | 0.063 | Potassium channel (ATP-sensitive) blocker | |||
| 0.079 | 0.071 | 0.079 | mTOR complex 2 inhibitor | |||
| 0.031 | 0.023 | 0.031 | ATP citrate lysase inhibitor | |||
| 0.034 | 0.026 | 0.034 | Phosphoglycerate kinase inhibitor | |||
| 0.026 | 0.018 | 0.026 | Prostaglandin EP4 antagonist | |||
| 0.063 | 0.056 | 0.063 | Glutamate (mGluR7) antagonist | |||
| 0.037 | 0.029 | 0.037 | Glutamate (mGluR8) agonist | |||
| 0.033 | 0.027 | 0.033 | Retinoid X receptor agonist | |||
| 0.074 | 0.068 | 0.074 | Phosphodiesterase IV inhibitor | |||
| 0.026 | 0.02 | 0.107 | Sodium/glucose cotransporter 2 inhibitor | 0.107 0.003 CID_124202102 | CID_124202102 | |
| 0.019 | 0.013 | 0.032 | Antibiotic Anthracycline-like | 0.032 0.003 CID_124202102 | CID_124202102 | |
| 0.04 | 0.034 | 0.055 | Guanylate cyclase inhibitor | 0.055 0.017 CID_124202102 | CID_124202102 | |
| 0.043 | 0.039 | 0.043 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.041 | 0.037 | 0.041 | Glycine transporter 2 inhibitor | |||
| 0.019 | 0.015 | 0.019 | Retinoic acid alpha receptor antagonist | |||
| 0.08 | 0.076 | 0.162 | Triose-phosphate isomerase inhibitor | 0.162 0.017 CID_124202102 | CID_124202102 | |
| 0.028 | 0.025 | 0.028 | Prostaglandin agonist | |||
| 0.036 | 0.034 | 0.036 | Retinoic acid alpha receptor agonist | |||
| 0.046 | 0.044 | 0.123 | Protein 50S ribosomal subunit inhibitor | 0.123 0.009 CID_124202102 | CID_124202102 | |
| 0.021 | 0.02 | 0.021 | ICAM 1 antagonist | |||
| 0.045 | 0.044 | 0.045 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.107 | 0.106 | 0.182 | DNA repair enzyme inhibitor | 0.182 0.013 CID_124202102 | CID_124202102 | |
| 0.066 | 0.065 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.058 | 0.058 | 0.138 | Phosphofructokinase-1 inhibitor | 0.138 0.02 CID_124202102 | CID_124202102 | |
| 0.022 | 0.027 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 CID_124202102 | CID_124202102 | |
| 0.017 | 0.025 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.021 0.017 CID_124202102 | CID_124202102 | |
| 0.012 | 0.03 | 0.017 | Telomerase stimulant | 0.017 0.013 CID_124202102 | CID_124202102 | |
| 0.091 | 0.11 | 0.307 | Cell adhesion inhibitor | 0.307 0.01 CID_124202102 | CID_124202102 | |
| 0.112 | 0.133 | 0.369 | Hemostatic | 0.369 0.01 CID_124202102 | CID_124202102 | |
| 0.065 | 0.087 | 0.121 | Glycine receptor antagonist | 0.121 0.018 CID_124202102 | CID_124202102 | |
| 0.116 | 0.14 | 0.149 | CC chemokine 6 receptor antagonist | 0.149 0.024 CID_124202102 | CID_124202102 | |
| 0.078 | 0.105 | 0.125 | Interleukin 12 antagonist | 0.125 0.025 CID_124202102 | CID_124202102 | |
| 0.015 | 0.044 | 0.049 | Squalene synthetase inhibitor | 0.049 0.015 CID_124202102 | CID_124202102 | |
| 0.008 | 0.038 | 0.023 | Ileal bile acid transport inhibitor | 0.023 0.007 CID_124202102 | CID_124202102 | |
| 0.062 | 0.102 | 0.093 | Falcipain 2 inhibitor | 0.093 0.057 CID_124202102 | CID_124202102 | |
| 0.038 | 0.078 | 0.081 | Alpha-mannosidase inhibitor | 0.081 0.011 CID_124202102 | CID_124202102 | |
| 0.064 | 0.106 | 0.095 | Falcipain inhibitor | 0.095 0.059 CID_124202102 | CID_124202102 | |
| 0.003 | 0.05 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 CID_124202102 | CID_124202102 | |
| 0.102 | 0.149 | 0.251 | Insulin secretagoues | 0.251 0.019 CID_124202102 | CID_124202102 | |
| 0.042 | 0.089 | 0.079 | Nitric oxide donor | 0.079 0.023 CID_124202102 | CID_124202102 | |
| 0.029 | 0.08 | 0.051 | Microtubule stabilization | 0.051 0.027 CID_124202102 | CID_124202102 | |
| 0.024 | 0.09 | 0.072 | Mannosidase inhibitor | 0.072 0.011 CID_124202102 | CID_124202102 | |
| 0.012 | 0.08 | 0.054 | Protein 30S ribosomal subunit inhibitor | 0.054 0.007 CID_124202102 | CID_124202102 | |
| 0.03 | 0.103 | 0.348 | Selectin antagonist | 0.348 0.004 CID_124202102 | CID_124202102 | |
| 0.014 | 0.093 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 CID_124202102 | CID_124202102 | |
| 0.02 | 0.098 | 0.054 | Phosphorylase inhibitor | 0.054 0.028 CID_124202102 | CID_124202102 | |
| 0.053 | 0.136 | 0.162 | Cell adhesion molecule inhibitor | 0.162 0.013 CID_124202102 | CID_124202102 | |
| 0.016 | 0.138 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 CID_124202102 | CID_124202102 | |
| 0.019 | 0.161 | 0.074 | Antibiotic Aminoglycoside-like | 0.074 0.005 CID_124202102 | CID_124202102 | |
| 0.056 | 0.215 | 0.314 | Thrombolytic | 0.314 0.022 CID_124202102 | CID_124202102 | |
| 0.058 | 0.285 | 0.128 | Diuretic | 0.128 0.097 CID_124202102 | CID_124202102 | |
| 0.05 | 0.316 | 0.081 | T cell inhibitor | 0.081 0.061 CID_124202102 | CID_124202102 | |
| 0.029 | 0.297 | 0.093 | DNA intercalator | 0.093 0.082 CID_124202102 | CID_124202102 | |
| 0.121 | 0.423 | 0.714 | Cyclophilin D inhibitor | 0.714 0.013 CID_124202102 | CID_124202102 | |
| 0.016 | 0.521 | 0.064 | Factor IXa inhibitor | 0.064 0.024 CID_124202102 | CID_124202102 | |
| 0.028 | 0.735 | 0.31 | Immunomodulator | 0.31 0.077 CID_124202102 | CID_124202102 | |
| 0.008 | 0.76 | 0.167 | Anticoagulant | 0.167 0.068 CID_124202102 | CID_124202102 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |